Lantern Pharma Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Lantern Pharma Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2019 to Q2 2024.
  • Lantern Pharma Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 10.8M shares, a 1.01% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 10.8M -110K -1.01% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 10.8M -98.2K -0.91% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 10.7M -136K -1.25% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 10.9M +12K +0.11% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 10.9M +38.1K +0.35% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 10.9M +26.1K +0.24% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 10.9M -232K -2.09% Dec 31, 2022 10-K 2024-03-18
Q3 2022 10.9M -330K -2.95% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 10.8M -353K -3.16% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 10.8M -351K -3.14% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 11.1M +4.87M +78.3% Dec 31, 2021 10-K 2023-03-20
Q3 2021 11.2M +4.97M +79.9% Sep 30, 2021 10-Q 2021-11-01
Q2 2021 11.2M +4.97M +79.9% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 11.2M Mar 31, 2021 10-Q 2021-05-03
Q4 2020 6.22M +4.24M +214% Dec 31, 2020 10-K 2022-03-10
Q3 2020 6.22M Sep 30, 2020 10-Q 2020-10-29
Q2 2020 6.22M Jun 30, 2020 10-Q 2020-07-30
Q4 2019 1.98M Dec 31, 2019 10-K 2021-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.